In agreement with our identification of HMGA2 as an important driver of CHOL carcinogenesis, overexpression of HMGA2 was reported in various cancers [62,63], and it was implicated in tumor metastasis, poor prognoses, and therapy failures in various cancer [64,65]. This evidence concerns the gene HMGA2 and neoplasm.